Delhi court permanently restrains Sainus Pharma from using ‘Udaan’ mark
A Delhi court has barred Hyderabad-based Sainus Pharmaceutical from using the ‘Udaan’ name, finding it deceptively similar to RSPL Health’s ‘Udan’ sanitary-napkin brand. Seized products, packaging and related materials must be handed to RSPL for destruction.
What happened
RSPL Health Private Limited · A Delhi court permanently barred Hyderabad-based Sainus Pharmaceutical from using the 'Udaan' mark, finding it deceptively similar
Key facts
- 2007
- August 13
Why this matters
For acquirers and partners, the ruling highlights the value of trademark diligence in personal care, while strengthening the defensibility of RSPL Health’s Udan brand assets.
What to watch
- Any appeal, stay request or compliance filing by Sainus Pharmaceutical.
- Evidence of seized stock destruction and the speed of Udaan product delisting from wholesalers and ecommerce platforms.
- A new Sainus feminine-care brand launch, including whether it retains similar colors, claims, pack architecture or distribution partners.
- RSPL advertising, price promotions, SKU expansion or increased retail visibility for Udan following the injunction.
- New trademark enforcement actions by RSPL against other personal-care marks resembling Udan/Udaan.
- RSPL is likely to notify distributors, pharmacy chains, ecommerce marketplaces and trade associations of the injunction to accelerate delisting of Udaan-labelled stock.
- RSPL may use the ruling to pursue additional takedowns against similar spellings, packaging cues or marketplace listings in feminine hygiene.
- Sainus is likely to assess appeal options while preparing a replacement brand, revised packaging and fresh regulatory/commercial materials.
- Retailers and online platforms may tighten trademark-document checks for sanitary-napkin listings, especially for brands with similar Hindi phonetics.